Harbour Investments’s Dr. Reddy's Laboratories RDY Stock Holding History

Harbour Investments’s Portfolio RDY Stock Details RDY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.88K	Sell	130 -31	-19%	-$418	﹤0.01%	4040
2026 Q1	$2.23K	Buy	161 +31	+24%	+$432	﹤0.01%	3875
2025 Q4	$1.82K	Hold	130	–	–	﹤0.01%	3324
2025 Q3	$1.82K	Hold	130	–	–	﹤0.01%	3298
2025 Q2	$1.95K	Hold	130	–	–	﹤0.01%	3139
2025 Q1	$1.72K	Hold	130	–	–	﹤0.01%	3127
2024 Q4	$2.05K	Hold	130	–	–	﹤0.01%	3014
2024 Q3	$2.07K	Hold	130	–	–	﹤0.01%	2916
2024 Q2	$1.98K	Hold	130	–	–	﹤0.01%	2816
2024 Q1	$1.91K	Hold	130	–	–	﹤0.01%	2793
2023 Q4	$1.81K	Sell	130 -3,750	-97%	-$50.1K	﹤0.01%	2711
2023 Q3	$51.9K	Buy	3,880 +3,750	+2,885%	+$50.7K	﹤0.01%	1335
2023 Q2	$1.64K	Buy	+130	New	+$1.52K	﹤0.01%	2596
2021 Q4	–	Sell	-195	Closed	-$3K	–	3468
2021 Q3	$3K	Buy	195 +5	+3%	+$67	﹤0.01%	3217
2021 Q2	$3K	Hold	190	–	–	﹤0.01%	3271
2021 Q1	$2K	Buy	+190	New	+$2.44K	﹤0.01%	3256

Other funds holding RDY

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

AIM

Aikya Investment Management London, United Kingdom $341M AUM 28.74% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Harbour Investments's RDY Position: Q2 2026 in Review

Harbour Investments reduced its Dr. Reddy's Laboratories (RDY) stake by 19% in Q2 2026, selling an estimated $418 and leaving 130 shares worth $1.88K. The position accounts for ﹤0.01% of the portfolio, ranked #4040.

Harbour Investments first reported a position in RDY in Q1 2021 and has held it in 16 quarters since. The position peaked at $51.9K in Q3 2023. 238 funds tracked by Wall St. Rank hold RDY as of Q2 2026.

Harbour Investments held 130 shares of Dr. Reddy's Laboratories worth $1.88K as of Q2 2026.
Harbour Investments sold 31 Dr. Reddy's Laboratories shares in Q2 2026, an estimated $418.
Dr. Reddy's Laboratories made up ﹤0.01% of Harbour Investments's portfolio in Q2 2026, its #4040 holding.
Harbour Investments first reported a position in Dr. Reddy's Laboratories in Q1 2021 and has held it in 16 quarters since.
Harbour Investments's Dr. Reddy's Laboratories position peaked at $51.9K in Q3 2023.
238 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2026.

Based on Harbour Investments's 13F filing for Q2 2026, filed 12 Aug 2026.